PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1054
https://www.valueinhealthjournal.com/article/S1098-3015(11)02616-7/fulltext
Title :
PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02616-7&doi=10.1016/j.jval.2011.08.1054
First page :
A425
Section Title :
Research On Methods
Open access? :
No
Section Order :
1016